Selecting the RIGHT Patient for Systemic Therapy in cSCC: A Care Team Forum

Program Overview

The recent approval of the first immunotherapeutic agent for cutaneous squamous cell carcinoma (cSCC) is changing the way healthcare providers treat patients with inoperable cSCC. In this roundtable discussion, a survivor of cSCC draws upon his experience with the cancer when surgery and chemotherapy failed him, as our multidisciplinary faculty panel focus on how to optimally select patients with cSCC for treatment with immunotherapy.

Credit Expired

Target Audience

The intended audience for this activity is Mohs surgeons, medical oncologists, and dermatologists who manage patients with cutaneous squamous cell carcinoma (cSCC).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Identify patients with cutaneous squamous cell carcinoma (cSCC) who are unlikely to be cured by surgery to expedite appropriate workup, multidisciplinary team collaboration, and referral for systemic therapy (including immunotherapy) to improve patient outcomes and quality of life
Incorporate shared decision making (SDM), quality of life assessment and management, and collaborative care for patients with cSCC to improve patient outcomes

Activity Faculty

Chrysalyne D. Schmults, MD, MSCE

Associate Professor, Dermatology
Harvard Medical School
Director, Mohs and Dermatologic Surgery Center
Dana-Farber/Brigham and Women’s Cancer Center
Boston, MA

Omid Hamid, MD

Chief, Translational Research and Immunotherapy
Director, Cutaneous Oncology
The Angeles Clinic and Research Institute
Los Angeles, CA

Anokhi Jambusaria, MD, MSCE, FAAD

Assistant Professor, Division of Dermatology
Department of Internal Medicine
The University of Texas
Austin Dell Medical School
Austin, TX

Featured RMEI CE Activities

Selecting the RIGHT Patient for Systemic Therapy in cSCC: A Care Team Forum

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Chrysalyne D. Schmults, MD, MSCE

Omid Hamid, MD

Anokhi Jambusaria, MD, MSCE, FAAD

Patient Perspectives in Food Allergy: Advances in Treatment Strategies to Address Unmet Needs

Bolstering the Bronchi: Emerging Therapeutic Strategies for Patients with NCFBE

Targeted Approaches to CMV Management: Alleviating the Patient Burden from Prevention to Refractory Disease

Navigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®

Company

Subscribe